We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Biotech Growth Trust (the) Plc | BIOG | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
912.00 | 908.00 | 924.00 | 922.00 | 907.00 |
Industry Sector |
---|
EQUITY INVESTMENT INSTRUMENTS |
Top Posts |
---|
Posted at 02/10/2024 14:10 by sharesoc Geoff Hsu, General Partner at OrbiMed Capital, will present The Biotech Growth Trust (BIOG) and will discuss its current performance and future strategies on the ShareSoc webinar taking place on the 17th October 2024 at 4 p.m on Zoom. The presentation will be followed by a Q&A session, where you can ask Geoff direct questions. |
Posted at 16/11/2022 07:54 by ali47fish biog update new chair some improvement |
Posted at 09/12/2021 11:31 by steeplejack Questor in Daily Telegraph (9 Dec) recommends BIOG after marked underperformance in 2021. |
Posted at 29/11/2021 19:03 by steeplejack Oh dear,not popular comments i see.Thing is,over the last five years,BIOG is up 57%,over the same period SMT is up 375%.Investment is about opportunity cost as we all know.Now compared with Astra or Pfizer,the underperformance is that much less,over five years the former is up 97% and the latter up 77%.(Generously,i |
Posted at 28/7/2021 15:47 by daveoz1 Absolutely ali47fish - I did a lot of investing about 4 months ago and BIOG has been by far the worst performing fund of those that I bought then, especially in the last few days! Finding it very hard to find out reasons for this. Slightly better today, but I'm hoping it improves a LOT more! |
Posted at 16/7/2021 10:52 by tomps2 John Rosier mentions Biotech Growth (BIOG) in the latest PIWORLD interview at 12m14sWatch the video here: Or listen to the podcast here: |
Posted at 09/6/2021 06:11 by steeplejack 2.5% of BIOG portfolio represented by Biogen which jumped some 40% in the US yesterday following FDA approval of its Alzheimer drug. |
Posted at 06/3/2021 19:31 by cliff007 Ali. That's what I meant. I'm wondering what's going on. Another Investment Trust I have WWH, has suffered the same fate so I don't believe it's BIOG specific. I'm holding on..... |
Posted at 01/8/2019 15:04 by healthtech That's because IBT has a dividend yield of 4% and has outperformed its index. Seems like YTD BIOG is performing better, but need to sustain this to improve its long term performance. |
Posted at 29/7/2019 15:56 by rogerrail IBT on slight premium to NAV whereas BIOG at a discount . Very similar funds, I would expect BIOG to catch up at some point |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions